Christophe Soulier
Direttore Finanziario/CFO presso Janssen Pharmaceuticals, Inc.
Posizioni attive di Christophe Soulier
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Direttore Finanziario/CFO | 01/11/2007 | - |
Johnson & Johnson Innovation Ltd.
 Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | Investitore di Private Equity | 08/02/2023 | - |
Storia della carriera di Christophe Soulier
Precedenti posizioni note di Christophe Soulier
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| JOHNSON & JOHNSON | Direttore Finanziario/CFO | 01/04/2005 | 01/10/2007 |
| Investitore di Private Equity | 01/08/2002 | 01/04/2005 |
Formazione di Christophe Soulier
| University of Michigan | Masters Business Admin |
| Collège Stanislas de Paris | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Francia | 2 |
| Regno Unito | 2 |
Posizioni
| Director of Finance/CFO | 2 |
| Private Equity Investor | 2 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Aziende private | 2 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Johnson & Johnson Innovation Ltd.
Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | Finance |
- Borsa valori
- Insiders
- Christophe Soulier
- Esperienza
